JCI vs NEUP · P/E 44, rev $23.60B vs rev $15.7M
Johnson Controls International PLC (JCI) versus Neuphoria Therapeutics Inc (NEUP) — a side-by-side from cached financials, not a winner call.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Neuphoria Therapeutics Inc (NEUP) is a biotechnology company listed on NASDAQ.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Latest reported NEUP revenue for 2025-03-31 was $15.7M. Net income was $8.5M. NEUP currently screens at market cap $23.6M.
JCI currently screens at market cap $87.62B and trailing P/E 43.9. NEUP currently screens at market cap $23.6M.
Not investment advice. Open the JCI and NEUP stock pages for the full models.
Not investment advice.